Forbes Asia 100 To Watch 2025

Asia-Pacific’s small companies and startups on the rise.

O

ur fifth annual Forbes Asia 100 to Watch list provides a window into the vibrant world of startups and small companies in the Asia-Pacific region. It’s a constantly evolving ecosystem, which is increasingly focusing on AI and deep tech to innovate and thrive.

The promising news is that VC funding in the region, which had fallen to a ten-year low at the end of 2024, has seen an uptick in some countries this year. According to a recent KPMG report, India, Japan and Singapore are drawing more risk capital this year, a trend this compendium also reflects. A total of 16 countries and territories are represented on our list and India leads the pack with 18 companies, followed by Singapore and Japan (14 each), China (9), Indonesia and South Korea (8 each) and Australia (7).

Investors also favor fast-rising sectors such as biotechnology, spacetech and green tech, and our list is well-populated by companies in those fields—from enterprises developing gene-editing therapies for cancer treatments to those producing new anode material for lithium-ion batteries or building novel propulsion systems for spacecraft. They are grouped under ten industry categories with the largest cohort (18) in biotechnology and healthcare followed by enterprise technology and robotics (16). Overall, the 100 companies on the list have drawn nearly $3 billion in funding to date, compared with $2 billion raised by last year’s group.

Edited by Rana Wehbe Watson

Assistant editors: Catherine Wang and Yue Wang

Research and reporting: Jonathan Burgos, John Kang, Yessar Rosendar, Ian Sayson, James Simms, Jennifer Wells and Ardian Wibisono


METHODOLOGY: To select the finalists on the 100 to Watch list, Forbes Asia solicited online submissions, and invited accelerators, incubators, universities, venture capitalists and others to nominate companies as well. To qualify for consideration, companies had to be headquartered in the Asia-Pacific region, be privately owned for-profit ventures, and have no more than $50 million in annual revenue and no more than $100 million in total funding through Aug. 15. Our team evaluated each submission, weighing factors such as impact on and contribution to their industry and region, market fit, promising business model, innovation, track record of consistent revenue growth and the ability to attract funding.

*The editors reserve the right to remove or replace any company or individual included in the list in light of any new information that would disqualify them from inclusion.


Aetech

South Korea

Category: Energy & Green Tech

Year founded: 2020 • CEO: Taehyung Park

Aetech has devised an automated alternative to the laborious task of manually sorting waste: an AI-powered robot, Atron, which the startup says can double recycling efficiency. So far, some 20 Atrons have been deployed at South Korean waste management facilities, logistics centers and industrial complexes. With more than $13 million raised, including from GS Ventures, the VC arm of South Korea’s GS Group, it’s eyeing expansion into Australia, Singapore and Vietnam. Aetech took a bronze in the category of manufacturing and logistics production process innovation at the 2025 Edison Awards.


Aeterlink

Japan

Category: Industry & Manufacturing

Year founded: 2020 • CEO: Ryo Iwasa

Aeterlink, which started out at Stanford University, has developed wireless power transfer technologies for a range of applications, including in factory automation and building management. Its wireless temperature sensors for air conditioning units, for example, ensure cooled air is directed to where it’s needed. The Tokyo-based company has raised ¥6.8 billion ($46 million) in equity, debt and grants from the likes of Jafco Group, Sparx’s Mirai Creation Fund and Mizuho Capital, including ¥3.9 billion in a series B round in February.


Aether Fuels

Singapore

Category: Energy & Green Tech

Year founded: 2022 • CEO: Conor Madigan

This e-fuels startup has developed technologies to convert waste carbon feedstock into sustainable fuels for the aviation and shipping industries. Aether Fuels says it can convert materials such as agricultural waste and industrial waste gases into green fuels by extracting and processing carbon content in an economically viable way. It has inked agreements with Singapore Airlines and JetBlue to supply sustainable aviation fuel once it begins producing it on a commercial scale. Aether Fuels has raised over $40 million, including a $34 million series A round in June 2024 from investors such as AP Ventures and Temasek’s Xora Innovation.


Aevice Health

Singapore

Category: Biotechnology & Healthcare

Year founded: 2016 • CEO: Adrian Ang

Growing up with asthma led Adrian Ang to found medtech firm Aevice Health, which makes non-invasive, wearable devices that can help manage respiratory diseases remotely. The company’s AeviceMD is a smart wearable stethoscope that continuously monitors heart and respiratory rates. In May, AeviceMD received U.S. Food & Drug Administration clearance for its use on children above the age of three. Last year, the startup raised $7 million in a seed plus funding round led by Coronet Ventures, the Singapore-based venture unit of Cedars-Sinai Intellectual Property. Other investors include East Ventures, A&D Company and Seeds Capital.


AI Hay

Vietnam

Category: Consumer Technology

Year founded: 2022 • CEO: Duc Tran

AI Hay’s Vietnamese chatbot and app, based on a proprietary large language model, can identify linguistic patterns and cultural context as well as track user behavior to generate answers sourced from curated content. The mobile app is primarily used by students, and allows them to snap a photo of their assignments and receive step-by-step guidance for subjects such as math, literature and essay writing. It also offers social networking tools. In July, AI Hay raised $10 million in a series A round led by Argor Capital, bringing its total funding to over $18 million.


Aimed Bio

South Korea

Category: Biotechnology & Healthcare

Year founded: 2018 • CEO: Nam-Gu Her

Unlike chemotherapy, which harms healthy cells, antibody-based treatments that target only cancer cells have caught on. Seoul-based Aimed Bio is developing one such potent targeted therapy called antibody-drug conjugates, or ADCs. A spinoff from South Korea’s Samsung Medical Center, the biotech startup has also developed linker-payload technologies, which are crucial in ensuring the complex ADC treatments work. Aimed Bio has raised $82 million so far, including over $36 million in a June pre-IPO round from investors such as Intervest, DS Asset Management, Samsung Life Insurance Foundation, SMB Investment Partners and Mirae Asset Securities.


AlphaLife Sciences

Singapore

Category: Biotechnology & Healthcare

Year Founded: 2020 • CEO: Sharon Chen

Developing a new drug involves reams of clinical paperwork and preparing those manually is a laborious, time-consuming process. AlphaLife Sciences says its cloud-based medical writing tool AuroraPrime can help pharmaceutical companies draft clinical study reports and regulatory documents at record speed. A graduate of startup accelerators including Nvidia Inception and the Microsoft for Startups Pegasus program, the company has raised tens of millions in funding from investors such as Hankang Capital and B Capital.


Asuene

Japan

Category: Energy & Green Tech

Year Founded: 2019 • CEO: Kohei Nishiwada

Asuene offers a cloud-based CO₂ emissions management and carbon accounting platform, which helps companies measure and reduce their carbon footprint. With more than 10,000 customers, the Tokyo-based firm has raised a total of ¥10.6 billion ($71 million) from investors such as Salesforce Ventures, Sony Innovation Fund and Temasek-owned Pavilion Capital, including ¥5 billion garnered in a series C round last year.


Augmentus

Singapore

Category: Enterprise Technology & Robotics

Year Founded: 2019 • CEO: Daryl Lim

Augmentus has developed AI-powered industrial robotic systems that don’t require extensive coding. The company’s vision system–combining 3D scanning cameras that act as the robot’s “eyes” with its AutoPath software, which serves as the “brain”–enables the robot to collect and analyze spatial information to generate optimal toolpaths. In July, the company raised $11 million in a series A+ round led by South Korean investment firm Woori VP, with participation from EDBI, Sierra Ventures and Cocoon Capital.


BANF

South Korea

Category: Industry & Manufacturing

Year Founded: 2020 • CEO: Adam Sunghan You

Worn-out tires are often the cause of serious car crashes, which Seoul-based BANF says can be prevented by real-time monitoring and predictive analytics. The company has developed tire-mounted sensors that track tire pressure, temperature, tread depth, wheel alignment and road conditions, which can alert drivers to any potential hazards. BANF, which has partnered with Volvo, Hyundai and DHL, says its sensors can reduce tire-related accidents by 40%. The startup won an innovation award in the Vehicle Tech & Advanced Mobility category at CES 2024.


Base Therapeutics

China

Category: Biotechnology & Healthcare

Year Founded: 2021 • CEO: Xu Tianhong

This owner of over 30 global patents uses gene-editing technologies to develop treatments for advanced tumors. The Shanghai-based company’s flagship product is NK510, an injection of enhanced immune cells that can target and destroy cancer cells. Base Therapeutics has raised $34.5 million in funding from investors including Chinese search giant Baidu, Great Eagle VC and Gobi Partners. It plans to conduct clinical trials for the drug in Beijing later this year.


bitBiome

Japan

Category: Biotechnology & Healthcare

Year Founded: 2018 • CEO: Yuji Suzuki

Leave a Reply

Your email address will not be published.

Previous Story

7 Polka Dot Manicures, Motivated by Celebs

Next Story

Connie Francis Songs Being Re-Released in Wake of Vocalist’s Fatality

Don't Miss